- Stocks
- Healthcare
- NASDAQ: IGMS

Price (delayed)

$9.27

Market cap

$549.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.64

Enterprise value

$521.99M

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing

IGMS's revenue has surged by 74% year-on-year and by 38% since the previous quarter

IGM Biosciences's gross profit has surged by 74% YoY and by 38% QoQ

IGM Biosciences's equity has plunged by 53% YoY and by 24% from the previous quarter

IGM Biosciences's quick ratio has decreased by 22% YoY and by 12% QoQ

What are the main financial stats of IGMS

Market
Valuations
Earnings

Shares outstanding

59.32M

Market cap

$549.88M

Enterprise value

$521.99M

Price to earnings (P/E)

N/A

Price to book (P/B)

4.47

Price to sales (P/S)

192.45

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

179.32

Revenue

$2.91M

EBIT

-$219.92M

EBITDA

-$205.43M

Free cash flow

-$176.12M

Per share
Balance sheet
Liquidity

EPS

-$3.64

Free cash flow per share

-$2.91

Book value per share

$2.07

Revenue per share

$0.05

TBVPS

$5.57

Total assets

$336.5M

Total liabilities

$214.14M

Debt

$39.37M

Equity

$122.36M

Working capital

$228.36M

Debt to equity

0.32

Current ratio

7.06

Quick ratio

6.82

Net debt/EBITDA

0.14

Margins
Efficiency
Dividend

EBITDA margin

-7,057.1%

Gross margin

100%

Net margin

-7,571.4%

Operating margin

-8,144.7%

Return on assets

-54.7%

Return on equity

-119%

Return on invested capital

-74.8%

Return on capital employed

-73.6%

Return on sales

-7,554.8%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the IGM Biosciences stock price performed over time

Intraday

6.31%

1 week

2.32%

1 month

-10.61%

1 year

18.85%

YTD

11.55%

QTD

34.93%

How have IGM Biosciences's revenue and profit performed over time

Revenue

$2.91M

Gross profit

$2.91M

Operating income

-$237.09M

Net income

-$220.4M

Gross margin

100%

Net margin

-7,571.4%

IGMS's revenue has surged by 74% year-on-year and by 38% since the previous quarter

IGM Biosciences's gross profit has surged by 74% YoY and by 38% QoQ

IGM Biosciences's net margin has increased by 46% YoY and by 33% from the previous quarter

IGMS's operating margin is up by 45% year-on-year and by 32% since the previous quarter

What is IGM Biosciences's growth rate over time

What is IGM Biosciences stock price valuation

P/E

N/A

P/B

4.47

P/S

192.45

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

179.32

The EPS is up by 31% year-on-year and by 15% since the previous quarter

The stock's P/B is 60% above its last 4 quarters average of 2.8 but 9% below its 5-year quarterly average of 4.9

IGM Biosciences's equity has plunged by 53% YoY and by 24% from the previous quarter

IGMS's revenue has surged by 74% year-on-year and by 38% since the previous quarter

IGMS's price to sales (P/S) is 14% less than its last 4 quarters average of 222.8

How efficient is IGM Biosciences business performance

The return on sales is up by 46% year-on-year and by 33% since the previous quarter

IGMS's return on equity is down by 41% year-on-year and by 10% since the previous quarter

The ROA has contracted by 17% YoY

The return on invested capital has declined by 10% year-on-year but it rose by 2.6% since the previous quarter

What is IGMS's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for IGMS.

How did IGM Biosciences financials performed over time

The total assets is 57% greater than the total liabilities

The total assets has declined by 30% year-on-year and by 11% since the previous quarter

IGM Biosciences's current ratio has decreased by 22% YoY and by 12% QoQ

IGM Biosciences's debt is 68% less than its equity

IGMS's debt to equity has soared by 100% YoY and by 28% QoQ

IGM Biosciences's equity has plunged by 53% YoY and by 24% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Pricing data from and IEX Cloud.